SII to acquire 20 pc stake in IntegriMedical
SIIs expertise in vaccine manufacturing and global
distribution will be invaluable as we work towards making our technology more
widely accessible to patients worldwide, IntegriMedical Managing Director
Sarvesh Mutha said.N-FIS will be available in the Indian private market,
offering patients and healthcare providers an alternative to traditional
needle-based injections, SII said.The technologys advantages include the
elimination of needle-phobia, alleviation of pain during administration,
convenience of use, and prevention of needle-stick injuries and
cross-contamination, it added.
Vaccines manufacturer Serum Institute of India (SII) on
Friday said it is acquiring 20 per cent stake in IntegriMedical, to advance
needle-free injection system technology.
Read more@ https://www.devdiscourse.com/article/health/2941569-sii-to-acquire-20-pc-stake-in-integrimedical
Comments
Post a Comment